GE Healthcare has signed a multi-year $100m partnership agreement with Affidea, a European provider of diagnostic imaging, outpatient and cancer care services, for the installation of imaging and digital technologies across the Affidea network.

Under the agreement, GE Healthcare will deploy more than 200 equipment at Affidea’s network of centres in Europe.

The agreement also includes the provision of 50 ultrasound devices, 40 CT scanners, 60 MRIs and 30 X-rays machines in the next three years. GE Healthcare will also provide service for six years under the agreement.

Through the agreement, the two entities intend to finish activating Affidea’s imaging equipment fleet with data-driven, connected and networked functionality.

The two firms also plan to enable collaboration between clinicians, boost sub-specialisation and support businesses to improve operations in real-time.

Affidea will install Picture Archiving and Communication System (PACS)-driven post-processing centres with the latest technologies and performance analytics capabilities with imaging insights. For this purpose, Affidea will use GE Healthcare’s Edison intelligence platform.

Affidea Group CEO Giuseppe Recchi said: “In the era of data-driven healthcare, the potential to make a positive impact on patients and doctors’ experience is impressive.

“Our goal is to support doctors and our operational teams for the benefit of our patients by using data analytics as a new way of orchestrating patient care and improving their experience. We are very happy that we could collaborate with GE Healthcare on this important project, which will accelerate the delivery of data-driven precision health.”

Meanwhile, GE Healthcare Life Sciences has also made SpinOculation C-Pro Protocol Software, part of the Sepax C-Pro Cell Processing System, commercially available to boost cell therapy workflow.

GE Healthcare also announced over 30 imaging technologies and solutions and a digital developer platform, the Edison Developer Program, at RSNA19.